Human papillomavirus (HPV) infection is a virosis that affects women with genotypes that can lead to cervical cancer under the impetus of certain external factors such as early sexual intercourse, prolonged use of oral contraceptives and expression of cytokines at high concentrations. This study, which took place in Pointe-Noire and Brazzaville, Republic of Congo, between 7 December 2019 and 20 September 2021, involved a population of 250 young women in schools and in medical consultations. The prevalence of HPV using the GèneXpert real-time PCR technique is estimated at 38%, with a predominance of genotype 16 (38.9%). Concentrations of the cytokines TNFα and IL18 were measured using the ELISA technique, giving concentrations of 266.2 ng/mL and 89.5 ng/mL respectively. We noted a significant association between HPV carriage and the two cytokines in our study (P = 0.00017 and P ？ 0.0001 for TNFα and IL18 respectively) as the median concentrations of the two cytokines were significantly higher in participants infected with HPV compared with those who were not. Analysis of the area under the curve (AUC) values for TNFα (0.66) and IL18 (0.75) showed that IL18 was more sensitive than TNFα for the clinical prognosis of participants infected with HPV. This cytokine is a good marker for HPV infection in our study. In conclusion, this study highlights the high prevalence of HPV in young people and the extreme probability of exposure of the participants to cervical cancer. It calls for increased preventive action against HPV in this juvenile population.
References
[1]
Wakabayashi, R., Nakahama, Y., Nguyen, V. and Espinoza, J.L. (2019) The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis. Microorganisms, 7, Article 199. https://doi.org/10.3390/microorganisms7070199
[2]
McBride, A.A. (2021) Human Papillomaviruses: Diversity, Infection and Host Interactions. NatureReviewsMicrobiology, 20, 95-108. https://doi.org/10.1038/s41579-021-00617-5
Wolf, J., Kist, L.F., Pereira, S.B., Quessada, M.A., Petek, H., Pille, A., etal. (2024) Human Papillomavirus Infection: Epidemiology, Biology, Host Interactions, Cancer Development, Prevention, and Therapeutics. ReviewsinMedicalVirology, 34, e2537. https://doi.org/10.1002/rmv.2537
[5]
Parkin, D.M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global Cancer Statistics, 2002. CA:ACancerJournalforClinicians, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
[6]
Boumba, L.M.A., Qmichou, Z., Mouallif, M., Attaleb, M., Mzibri, M.E., Hilali, L., etal. (2015) Human Papillomavirus Genotypes Distribution by Cervical Cytologic Status among Women Attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville). JournalofMedicalVirology, 87, 1769-1776. https://doi.org/10.1002/jmv.24221
[7]
Bissala Nkounkou, R.B., Essangui Same, E.G., Kojom Foko, L.P., Nganga, P.C., Tsimba Lemba, P.C., Ngoulou Ntsiba, A.M., etal. (2023) Knowledge, Sexual Behaviors on Human Papillomavirus Infections and Associated Factors: Survey among Female Adolescents and Adults in the Republic of Congo. CancerResearchJournal, 11, 59-69. https://doi.org/10.11648/j.crj.20231102.14
[8]
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA:ACancerJournalforClinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
[9]
Zur Hausen, H. (2002) Papillomaviruses and Cancer: From Basic Studies to Clinical Application. NatureReviewsCancer, 2, 342-350. https://doi.org/10.1038/nrc798
[10]
Oyouni, A.A.A. (2023) Human Papillomavirus in Cancer: Infection, Disease Transmission, and Progress in Vaccines. JournalofInfectionandPublicHealth, 16, 626-631. https://doi.org/10.1016/j.jiph.2023.02.014
[11]
Djonouma, I. (2023) Typage du papillomavirus dans le dépistage du cancer du cervien chez les femmes séropositives à Bamako. Thesis, Université des Sciences, des Tech-niques et des Technologies de Bamako. https://www.bibliosante.ml/handle/123456789/5881
[12]
Tounkara, F.K., Téguété, I., Guédou, F.A., Goma-Matsétsé, E., Koné, A., Béhanzin, L., etal. (2020) Human Papillomavirus Genotype Distribution and Factors Associated among Female Sex Workers in West Africa. PLOSONE, 15, e0242711. https://doi.org/10.1371/journal.pone.0242711
[13]
Malanda, J.N., Mbon, J.B.N., Bambara, A.T., Ibara, G., Minga, B., Epala, B.N., etal. (2013) Douze années de fonctionnement du registre des cancers de Brazzaville. BulletinduCancer, 100, 135-139. https://doi.org/10.1684/bdc.2013.1701
[14]
Boumba, L., Mustapha, M., Hilali, L., Donatien, M. and Ennaji, M.M. (2015) Prevalence of Human Papillomavirus infection among Congolese Women with Normal Cervical Cytology. International Journal of Science and Research, 4, 521-526.
[15]
Moukassa, D., N’Golet, A., Lingouala, L.G., Eouani, M.L., Samba, J.B., Mambou, J.V., etal. Pre-Cancerous Lesions of Cervical Cancer in Pointe-Noire: Situation Analysis. Tropical Medicine, 67, 57-60.
[16]
Barbisan, G., Pérez, L.O., Contreras, A. and Golijow, C.D. (2012) TNF-α and IL-10 Promoter Polymorphisms, HPV Infection, and Cervical Cancer Risk. TumorBiology, 33, 1549-1556. https://doi.org/10.1007/s13277-012-0408-1
[17]
Puren, A.J., Fantuzzi, G., Gu, Y., Su, M.S. and Dinarello, C.A. (1998) Interleukin-18 (IFNgamma-Inducing Factor) Induces IL-8 and IL-1beta via Tnfalpha Production from Non-CD14+ Human Blood Mononuclear Cells. JournalofClinicalInvestigation, 101, 711-721. https://doi.org/10.1172/jci1379
[18]
Traoré, A.M. (2014) Molecular Characterization of High-Risk Human Papillomaviruses in Histological Sections of High-Grade Precancerous Lesions of the Cervix in Ouagadougou, [Master in Biology]. Unité de Formation et de Recherche en Sciences de la Vie et de la Terre, Université Joseph Ki-Zerbo.
[19]
Stanczuk, G.A., Sibanda, E.N., Tswana, S.A. and Bergstrom, S. (2003) Polymorphism at the—308-Promoter Position of the Tumor Necrosis Factor-Alpha (TNF-α) Gene and Cervical Cancer. InternationalJournalofGynecologicalCancer, 13, 148-153. https://doi.org/10.1136/ijgc-00009577-200303000-00008
[20]
Le Boedec, K. (2016) Sensitivity and Specificity of Normality Tests and Consequences on Reference Interval Accuracy at Small Sample Size: A Computer‐Simulation Study. VeterinaryClinicalPathology, 45, 648-656. https://doi.org/10.1111/vcp.12390
[21]
Wikipedia (2020) Papanicolaou Colouring. https://fr.wikipedia.org/w/index.php?title=Coloration_de_Papanicolaou&oldid=175107843
[22]
Cochran, W.G. (1952) The χ2 Test of Goodness of Fit. TheAnnalsofMathematicalStatistics, 23, 315-345. https://doi.org/10.1214/aoms/1177729380
[23]
Foko, L.P.K., Narang, G., Tamang, S., Hawadak, J., Jakhan, J., Sharma, A., etal. (2022) The Spectrum of Clinical Biomarkers in Severe Malaria and New Avenues for Exploration. Virulence, 13, 634-653. https://doi.org/10.1080/21505594.2022.2056966
[24]
Solomon, D., Davey, D., Kurman, R., Moriarty, A., O’Connor, D., Prey, M., etal. (2002) The 2001 Bethesda Systemterminology for Reporting Results of Cervical Cytology. JAMA, 287, 2114-2119. https://doi.org/10.1001/jama.287.16.2114
[25]
Nganga, P.C., Boumba, L.M.A., Tsimba, C.P.L., Tchibinda, F.G.L., Nkounkou, R.B.B., Ataboho, E.E., etal. (2022) Prevalence and Genotyping of Human Papillomavirus among Women in the Departments of Niari and Bouenza, Republic of the Congo. JournalofBiosciencesandMedicines, 10, 64-77. https://doi.org/10.4236/jbm.2022.101007
[26]
Moukassa, D., N’Golet, A., Lingouala, L.G., Eouani, M.L., Samba, J.B., Mambou, J.V., etal. (2007) Precancerous Lesions of Cervical Cancer in Pointe-Noire: Situation Analysis. MedicineTropical, 67, 57-60.
[27]
N’Golet, A., Koutoupot, B.R., Lubuélé, L., Moukassa, D. and Etoka, S.E. (2004) Les néoplasies cervicales intra épithéliales (CIN) à Brazzaville, Congo. Analyse de situation. AnnalesdePathologie, 24, 324-328. https://doi.org/10.1016/s0242-6498(04)93979-x
[28]
Tsimba Lemba, P.C., Boumba, L.M.A., Péré, H., Nganga, P.C., Veyer, D., Puech, J., etal. (2023) Human Papillomavirus Genotype Distribution by Cytological Status and Associated Risk Factors in the General Population of Congolese Women Living in Urban and Rural Areas: Implications for Cervical Cancer Prevention. InfectiousDiseasesNow, 53, Article 104762. https://doi.org/10.1016/j.idnow.2023.104762
[29]
Ogembo, R.K., Gona, P.N., Seymour, A.J., Park, H.S., Bain, P.A., Maranda, L., etal. (2015) Prevalence of Human Papillomavirus Genotypes among African Women with Normal Cervical Cytology and Neoplasia: A Systematic Review and Meta-Analysis. PLOSONE, 10, e0122488. https://doi.org/10.1371/journal.pone.0122488
[30]
Boumba, L.M.A., Qmichou, Z., Mouallif, M., Attaleb, M., Mzibri, M.E., Hilali, L., etal. (2015) Human Papillomavirus Genotypes Distribution by Cervical Cytologic Status among Women Attending the General Hospital of Loandjili, Pointe-Noire, Southwest Congo (Brazzaville). JournalofMedicalVirology, 87, 1769-1776. https://doi.org/10.1002/jmv.24221
[31]
Mboumba Bouassa, R., Nodjikouambaye, Z.A., Sadjoli, D., Adawaye, C., Péré, H., Veyer, D., etal. (2019) High Prevalence of Cervical High-Risk Human Papillomavirus Infection Mostly Covered by Gardasil-9 Prophylactic Vaccine in Adult Women Living in N’djamena, Chad. PLOSONE, 14, e0217486. https://doi.org/10.1371/journal.pone.0217486
[32]
Wei, F., Goodman, M.T., Xia, N., Zhang, J., Giuliano, A.R., D’Souza, G., etal. (2022) Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies. ClinicalInfectiousDiseases, 76, e692-e701. https://doi.org/10.1093/cid/ciac581
[33]
Rahimy, R.M.L. (2013) Carriage of High-Risk Human Papillomavirus Genotypes among Sexually Active Adolescent Girls in the City of Ouagadougou. Ph.D. Thesis, University of Ouagadougou.
[34]
Adams, A.R., Nortey, P.A., Dortey, B.A., Asmah, R.H. and Wiredu, E.K. (2019) Cervical Human Papillomavirus Prevalence, Genotypes, and Associated Risk Factors among Female Sex Workers in Greater Accra, Ghana. JournalofOncology, 2019, Article ID: 8062176. https://doi.org/10.1155/2019/8062176
[35]
Laher, F., Laher, F., Wallace, M., Grzesik, K., Jaspan, H., Bekker, L.-G., et al. (2013) High Rate of Multiple Concurrent Human Papillomavirus Infections among HIV-Uninfected South African Adolescents. JournalofImmunologicalTechniquesinInfectiousDiseases, 2, Article 1000106. https://doi.org/10.4172/2329-9541.1000106
[36]
Mbulawa, Z.Z.A., van Schalkwyk, C., Hu, N., Meiring, T.L., Barnabas, S., Dabee, S., etal. (2018) High Human Papillomavirus (HPV) Prevalence in South African Adolescents and Young Women Encourages Expanded HPV Vaccination Campaigns. PLOSONE, 13, e0190166. https://doi.org/10.1371/journal.pone.0190166
[37]
Mbulawa, Z.Z.A., Coetzee, D. and Williamson, A. (2015) Human Papillomavirus Prevalence in South African Women and Men According to Age and Human Immunodeficiency Virus Status. BMCInfectiousDiseases, 15, Article No. 459. https://doi.org/10.1186/s12879-015-1181-8
[38]
Watson-Jones, D., Baisley, K., Brown, J., Kavishe, B., Andreasen, A., Changalucha, J., etal. (2013) High Prevalence and Incidence of Human Papillomavirus in a Cohort of Healthy Young African Female Subjects. SexuallyTransmittedInfections, 89, 358-365. https://doi.org/10.1136/sextrans-2012-050685
[39]
Boumba, A.L. (2014) Molecular and Phylogenetic Characterization of Oncogenic Human Papillomaviruses Associated with Cervical Cancer and Study of the Polymorphism at Codon 72 of the p53 Gene in Congo. Doctorat Thesis, Université Hassan 1er.
[40]
Huraux, J.-M., Nicolas, J.-C., Agut, H. and Peigue-Lafeuille, H. (2003) Traité de virologie médicale. ESTEM.
[41]
Qmichou, Z., Khyatti, M., Berraho, M., Ennaji, M.M., Benbacer, L., Nejjari, C., etal. (2013) Analysis of Mutations in the E6 Oncogene of Human Papillomavirus 16 in Cervical Cancer Isolates from Moroccan Women. BMCInfectiousDiseases, 13, Article No. 378. https://doi.org/10.1186/1471-2334-13-378
[42]
Monsonego, J., Zerat, L., Syrjänen, K., Zerat, J.C., Smith, J.S. and Halfon, P. (2013) Prévalence des génotypes d’HPV chez les femmes en France: Implications pour le dépistage et la vaccination. GynécologieObstétrique&Fertilité, 41, 305-313. https://doi.org/10.1016/j.gyobfe.2013.03.003
[43]
Akcali, S., Goker, A., Ecemis, T., Kandiloglu, A.R. and Sanlidag, T. (2013) Human Papilloma Virus Frequency and Genotype Distribution in a Turkish Population. AsianPacificJournalofCancerPrevention, 14, 503-506. https://doi.org/10.7314/apjcp.2013.14.1.503
[44]
Kuassi-Kpede, A.P., Dolou, E., Zohoncon, T.M., Traore, I.M.A., Katawa, G., Ouedraogo, R.A., etal. (2021) Molecular Characterization of High-Risk Human Papillomavirus (HR-HPV) in Women in Lomé, Togo. BMCInfectiousDiseases, 21, Article No. 278. https://doi.org/10.1186/s12879-021-05956-5
[45]
Sagna, T., Djigma, F., Zeba, M., Bisseye, C., Karou, S.D., Ouermi, D., etal. (2010) Human Papillomaviruses Prevalence and Genital Co-Infections in HIV-Seropositive Women in Ouagadougou (Burkina Faso). PakistanJournalofBiologicalSciences, 13, 951-955. https://doi.org/10.3923/pjbs.2010.951.955
[46]
Tebeu, M.P., Ako, A., Nguefack, T.C., Tseunwo, T.C., Kengne, F.G. and Sando, Z. (2018) Epidemiology of HPV Infection in the Semi-Urban Region of Cameroon: The Experience of Baham Health District, West Cameroon. Health Sciences and Disease, 19, 40-45.
[47]
Long, D., Song, H. and Qu, P. (2021) Cytokines Profiles in Cervical Mucosa in Patients with Cervical High-Risk Human Papillomavirus Infection. TheJournalofInfectioninDevelopingCountries, 15, 719-725. https://doi.org/10.3855/jidc.12147
[48]
Otani, S., Fujii, T., Kukimoto, I., Yamamoto, N., Tsukamoto, T., Ichikawa, R., etal. (2019) Cytokine Expression Profiles in Cervical Mucus from Patients with Cervical Cancer and Its Precursor Lesions. Cytokine, 120, 210-219. https://doi.org/10.1016/j.cyto.2019.05.011
[49]
Chagas, B.S., de Cássia Pereira de Lima, R., de Sá Leitão Paiva Júnior, S., de Oliveira Silva, R.C., Cordeiro, M.N., da Costa Silva Neto, J., etal. (2019) Significant Association between IL10-1082/-819 and TNF-308 Haplotypes and the Susceptibility to Cervical Carcinogenesis in Women Infected by Human Papillomavirus. Cytokine, 113, 99-104. https://doi.org/10.1016/j.cyto.2018.06.014
[50]
Ali, K.S., Ali, H.Y.M. and Jubrael, J.M.S. (2012) Concentration Levels of IL-10 and TNF α Cytokines in Patients with Human Papilloma Virus (HPV) DNA+ and DNA− Cervical Lesions. JournalofImmunotoxicology, 9, 168-172. https://doi.org/10.3109/1547691x.2011.642419
[51]
Song, S., Lee, J., Lee, N., Saw, H., Kang, J. and Lee, K. (2008) Interferon-γ (IFN-γ): A Possible Prognostic Marker for Clearance of High-Risk Human Papillomavirus (HPV). GynecologicOncology, 108, 543-548. https://doi.org/10.1016/j.ygyno.2007.11.006
[52]
Hong, J.H., Kim, M.K., Lee, I.H., Kim, T.J., Kwak, S.H., Song, S.H., etal. (2010) Association between Serum Cytokine Profiles and Clearance or Persistence of High Risk Human Papillomavirus Infection. InternationalJournalofGynecologicalCancer, 20, 1011-1016. https://doi.org/10.1111/igc.0b013e3181e513e5
[53]
Song, S., Lee, J., Seok, O. and Saw, H. (2007) The Relationship between Cytokines and HPV-16, HPV-16 E6, E7, and High-Risk HPV Viral Load in the Uterine Cervix. GynecologicOncology, 104, 732-738. https://doi.org/10.1016/j.ygyno.2006.10.054
[54]
Meda, Z.C., Ramde, Z., Hien, H., Ilboudo, B., Ouattara, C.A., Traore, I., etal. (2023) Evaluation de l’effectivité du test Human papillomavirus (HPV) dans le cadre du dépistage des lésions précancéreuses du col de l’utérus au Burkina Faso: Cas du Centre hospitalier universitaire Souro Sanou (CHUSS) de Bobo-Dioulasso. Revued’ÉpidémiologieetdeSantéPublique, 71, Article 101540. https://doi.org/10.1016/j.respe.2023.101540
